Risk of Death Not Up in T2DM When Risk Factors Within Target
Little or no excess risk of death, MI, stroke for those with five risk-factor variables within target ranges
Comments Open on End of NIH Review for Gene Therapy Studies
NIH oversight panel no longer plans to review all applications for gene therapy experiments
Steps Provided for Discharging Patient From Practice
Letter should be sent informing patient of their discharge, providing at least 30 days' notice
Patient Portals Don’t Appear to Have Much Traction
Patients not accessing them, physicians not using full range of features
ACA Coverage Gains Include Workers Without Insurance
Reduction in uninsurance rate among this group larger than that of not-employed adults
Weight Gain After Quitting Smoking May Up T2DM Risk
But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality
Vit D Independently, Inversely Tied to Cholesterol in Children
Gene variants do not modify the associations of 25(OH)D with lipids
Practice Names, Logos Should Be Carefully Designed
The logo should be simple and easy to identify, should send a message about the medical practice
NIH Panel Will No Longer Review Gene Therapy Experiments
FDA will now assess gene therapy experiments and products as it does with other treatments, drugs
Labetalol Use Up for Patients With Preeclampsia and Asthma
Use of labetalol versus other antihypertensives linked to increased risk of status asthmaticus
